PAS
AVNS icon

Point72 Asia (Singapore)’s Avanos Medical AVNS Stock Holding History

Point72 Asia (Singapore)’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-5,120
Closed -$62.7K – 909
2025
Q2 		$62.7K Buy
5,120
+2,486
+94% +$31.3K 0.01% 551
2025
Q1 		$37.7K Buy
2,634
+2,019
+328% +$31.5K 0.01% 614
2024
Q4 		$9.79K Buy
+615
New +$12.2K ﹤0.01% 745

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Point72 Asia (Singapore)'s AVNS Position: Q3 2025 in Review

Point72 Asia (Singapore) sold out of Avanos Medical (AVNS) in Q3 2025, closing a stake of 5,120 shares — an estimated $62.7K sold.

Point72 Asia (Singapore) first reported a position in AVNS in Q4 2024 and held it in 3 quarters. The position peaked at $62.7K in Q2 2025. 276 funds tracked by Wall St. Rank hold AVNS as of Q3 2025.

  • Point72 Asia (Singapore) reported no remaining Avanos Medical position as of Q3 2025 after selling out during the quarter.
  • Point72 Asia (Singapore) sold 5,120 Avanos Medical shares in Q3 2025, an estimated $62.7K.
  • Point72 Asia (Singapore) first reported a position in Avanos Medical in Q4 2024 and held it in 3 quarters.
  • Point72 Asia (Singapore)'s Avanos Medical position peaked at $62.7K in Q2 2025.
  • 276 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q3 2025, filed 14 Nov 2025.